A better UK human tissue bill

This time last year, the British research community was fuming over a piece of draft legislation that was, in the general view, a potential disaster for science.

Written byStephen Pincock
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

This time last year, the British research community was fuming over a piece of draft legislation that was, in the general view, a potential disaster for science. The Human Tissue Bill had been drawn up quickly in the wake of public outcry about the removal and storage of deceased children's organs at hospitals. It aimed to put consent at the heart of any situation where human tissue was being removed or retained.

But the bill as originally written would have threatened vital research, because it lacked clarity over issues relating to consent and anonymity of samples said many, including Robert May, president of the Royal Society, and Nick Wright, president of the Pathological Society of Great Britain and Ireland. Mark Walport of the Wellcome Trust called the bill "a confusing mix of contradictions and ambiguities, which could result in an unworkable, bureaucratic system that stifles legitimate research." Wright's take was ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies